Deciding about mammograms for women 75 and older
Breast Cancer Screening Decision Aid: A Survey-based Comparison of Video and Written Formats
This study will test whether a short video decision aid or a written decision aid better helps women 75 and older who have had mammograms before decide about future breast cancer screening.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 75 Years and up |
| Sex | Female |
| Sponsor | Yale University Academic / other |
| Locations | 1 site (New Haven, Connecticut) |
| Trial ID | NCT07515846 on ClinicalTrials.gov |
What this trial studies
This randomized online survey compares two decision aids—a video and a written tool—delivered through the YouGov platform to women aged 75 and older. Eligible participants have had at least one prior mammogram and have no history of breast cancer or ductal carcinoma in situ. The trial measures intention to screen in the future, readiness to make a decision about screening, and knowledge about mammography after exposure to one of the decision aids. Participants are randomized to one of the two aids and complete outcome measures via the online survey.
Who should consider this trial
Good fit: Women aged 75 and older who speak English, have had at least one prior mammogram, have no history of breast cancer or DCIS, and can complete an online survey are ideal candidates.
Not a fit: Women with a prior history of breast cancer or DCIS, those who cannot use online tools or do not speak English, and women under age 75 are unlikely to benefit from this study.
Why it matters
Potential benefit: If successful, the preferred decision aid could help older women make clearer, better-informed choices about whether to continue mammography, supporting shared decision-making.
How similar studies have performed: Decision aids for cancer screening have improved knowledge and decision readiness in other groups, but direct comparisons of video versus written aids in women 75 and older are limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * No prior history of breast cancer or ductal carcinoma in situ * Screened at least once before * English-speaking * Able to complete an online survey * Did not opt out of participation Exclusion Criteria: * Prior history of breast cancer or ductal carcinoma in situ
Where this trial is running
New Haven, Connecticut
- Yale School of Medicine — New Haven, Connecticut, United States (Recruiting)
Study contacts
- Principal investigator: Ilana Richman, MD — Yale University
- Study coordinator: Ilana Richman, MD
- Email: ilana.richman@yale.edu
- Phone: 203 737 1024
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.